Current Status of Imaging of Sjogren's Syndrome
Overview
Affiliations
Primary Sjögren's syndrome (pSS) is an autoimmune disease, which involves salivary glands (SG) and extra glandular organs. Today, Sjögren's patients' diagnosis is based on classification criteria taking into account five objective tests, including histology, immunology, two ophthalmological tests, and salivary flow evaluation. To date, the challenge is to find the right imaging tool for diagnosis, follow up, and prognosis of pSS. The objective of this review is to describe as to what are these imaging modalities and particularly the place and validity of salivary glands ultrasonography (SGUS) in the diagnosis and follow-up strategy of patients with suspected pSS. Moreover, new noninvasive tools are emerging, including elastography, a new ultrasonography technique that provides an estimate of tissue elasticity, MRI, MR sialography, and fluorodeoxyglucose-positron emission tomography. Although new imaging opportunities are available, SGUS should be the first-line choice in pSS because of its accessibility, feasibility over time, and sensitivity to change.
Multiple Bilateral Parotid Calcifications in a Patient with Sjögren's Syndrome: A Case Report.
Amirchaghmaghi M, Imanimoghaddam M, Pakfetrat A, Bozorgi Baee M J Dent (Shiraz). 2024; 25(4):388-392.
PMID: 39713111 PMC: 11662168. DOI: 10.30476/dentjods.2024.100095.2189.
Examination of parotid gland in diabetics with ultrasound elastography and microvascular imaging.
Erdem S, Tosun A Med Oral Patol Oral Cir Bucal. 2024; 30(1):e117-e123.
PMID: 39396136 PMC: 11801687. DOI: 10.4317/medoral.26865.
A bibliometric analysis of primary Sjögren's syndrome-associated lymphoma from 1991 to 2022.
Wu T, Li S, Chen J, Liao J, Huang Z, Yang J Heliyon. 2023; 9(11):e21337.
PMID: 37964859 PMC: 10641173. DOI: 10.1016/j.heliyon.2023.e21337.
Lu C, Huang Y, Hsieh S, Li K J Med Ultrasound. 2023; 31(2):112-118.
PMID: 37576413 PMC: 10413402. DOI: 10.4103/jmu.jmu_173_21.
Muntean D, Lenghel L, Stefan P, Fodor D, Badarinza M, Csutak C Cancers (Basel). 2023; 15(5).
PMID: 36900173 PMC: 10000076. DOI: 10.3390/cancers15051380.